Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

 » More

Comments (0) | Trackbacks (0) | Permalink

Changing the Paradigm of Substance Dependent Treatment

Catasys Health - Wednesday, December 02, 2009

How OnTrak is Different - We function as a provider in your network and your MBHO’s network, complementing your existing delivery system. We go much deeper than your current programs to address the uniquely difficult needs of your high-utilizing substance dependent members. » More



Comments (0) | Trackbacks (0) | Permalink

Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More



Comments (0) | Trackbacks (0) | Permalink

Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: » More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
naloxone hospitalizations opiod-based overdose Journal of Psychopharmacology substance use disorder placebo-controlled marijuana Raymond Anton codeine smoking relapse contract craving score psychosocial chronic pain CIWA OnTrak hydrocodone anxiety alcohol drinking pain medication dependence issues Harold Urschel facebook drinking heroin mental illness Co Occurring Disorders identification recovery stratified data mining meth painkillers post-traumatic stress disorder craving primary care health reform opioid abuse stimulants alcoholism trauma narcotic behavioral healthcare services PTSD suboxone buprenorphine addiction treatment Catasys behavioral health care reducing craving ADD SD health insurance relapse prevention treatment hospital behavioral health behavioral health care services emergency room ADHD SD members nicotine flumazenil predictive modeling behavioral healthcare reduction in craving depression screening substance dependence health insurance reduction in use addict medical and behavioral costs addiction social network methamphetamine OxyContin care coaching muscle relaxant pain pills opiates morphine health insurance drug addiction cigarettes binge drinking alcohol treatment high-utilizing Health Care Utilization prescriptions sugar fentanyl Opioid Treatment methadone withdrawal drug abuse alcohol dependence oxycodone vivitrol gabapentin opioid antagonist substance dependence stress Research Across America drug use alcohol drug addicts opiod abuse over-the-counter substances health plan bipolar disorder cocaine treatment Opioid Medications double-blind medical costs opioid overdose sober ER recovery network drug treatment sobriety prometa mental health randomized urine drug screen substance dependence costs communication pain killers physician- patient relations opioid-drug interactions percocet cocaine diabetes depression vicodin UnitedHealthcare opioid placebo methamphetamine dependence medical
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025